Skip to main content
SpringerLink
Log in
Book cover

Advances in Stem Cell Therapy pp 3–18Cite as

Hematopoietic Stem Cell Transplantation in Pediatric Diseases

  • Chapter
  • First Online:

  • 1437 Accesses

Part of the book series: Stem Cell Biology and Regenerative Medicine ((STEMCELL))

Abstract

Since the first successful hematopoietic stem cell transplantation (HSCT) in 1968, HSCT is currently a well-accepted treatment option for not only hematological diseases but also for immunodeficiency syndromes, solid tumors, and metabolic, rheumatological, and neurological disorders. Stem cell therapies are mainly classified as hematopoietic and mesenchymal stem cell therapies. Similar to adults, the main field of hematopoietic stem cell therapy in pediatric age group is hematopoietic stem cell transplantation (HSCT). The conditioning and the graft-versus-host disease (GVHD) prophylactic regimens have improved in the recent years associated with advancement in understanding of transplant biology; and these regimens are increasingly being tailored according to underlying disease, donor type, and stem cell source. The improvements in the supportive care of these patients including those for infectious complications and sinusoidal obstruction syndromes (SOS) have decreased the related morbidities and mortalities. Furthermore, our knowledge about the regenerative potential of hematopoietic stem cells is expanding.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Dini G, Giardino S. HSCT for children and adolescents, acute myeloid leukemia. In: Apperley J, editor. EBMT handbook. 6th ed. Paris: ESH; 2012. p. 491–8.

    Google Scholar 

  2. Tarlock K, Meshinchi S. Pediatric acute myeloid leukemia: biology and therapeutic implications of genomic variants. Pediatr Clin North Am. 2015;62:75–93.

    Article  PubMed  Google Scholar 

  3. Vettenranta K, EBMT Paediatric Working Party. Current European practice in pediatric myeloablative conditioning. Bone Marrow Transplant. 2008;41 Suppl 2:S14–7.

    Article  PubMed  Google Scholar 

  4. Nemecek ER, Guthrie KA, Sorror ML, Wood BL, Doney KC, Hilger RA, et al. Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies. Biol Blood Marrow Transplant. 2011;17:341–50.

    Article  CAS  PubMed  Google Scholar 

  5. Suciu S, Mandelli F, de Witte T, Zittoun R, Gallo E, Labar B, et al. Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial. Blood. 2003;102:1232–40.

    Article  CAS  PubMed  Google Scholar 

  6. Alyea EP, Kim HT, Ho V, Cutler C, DeAngelo DJ, Stone R, et al. Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant. 2006;12:1047–55.

    Article  PubMed  Google Scholar 

  7. Bader P, Kreyenberg H, Hoelle W, Dueckers G, Kremens B, Dilloo D, et al. Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective. Bone Marrow Transplant. 2004;33:815–21.

    Article  CAS  PubMed  Google Scholar 

  8. Peters CS. HSCT for children and adolescents, acute lymphoblastic leukemia. In: Apperley J, editor. EBMT handbook. 6th ed. Paris: ESH; 2012. p. 501–10.

    Google Scholar 

  9. Raimondi SC, Zhou Y, Mathew S, Shurtleff SA, Sandlund JT, Rivera GK, Behm FG, Pui CH. Reassessment of the prognostic significance of hypodiploidy in pediatric patients with acute lymphoblastic leukemia. Cancer. 2003;98:2715–22.

    Article  PubMed  Google Scholar 

  10. Jacobsohn DA, Hewlett B, Morgan E, Tse W, Duerst RE, Kletzel M. Favorable outcome for infant acute lymphoblastic leukemia after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11:999–1005.

    Article  PubMed  Google Scholar 

  11. Conter V, Valsecchi MG, Parasole R, Putti MC, Locatelli F, Barisone E, Lo Nigro L, Santoro N, Aricò M, Ziino O, Pession A, Testi AM, Micalizzi C, Casale F, Zecca M, Casazza G, Tamaro P, La Barba G, Notarangelo LD, Silvestri D, Colombini A, Rizzari C, Biondi A, Masera G, Basso G. Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study. Blood. 2014;123:1470–8.

    Article  CAS  PubMed  Google Scholar 

  12. Schrappe M, Valsecchi MG, Bartram CR, Schrauder A, Panzer-Grümayer R, Möricke A, et al. Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood. 2011;118:2077–84.

    Article  CAS  PubMed  Google Scholar 

  13. Dopfer R, Henze G, Bender-Götze C, Ebell W, Ehninger G, Friedrich W, et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. Blood. 1991;78:2780–4.

    CAS  PubMed  Google Scholar 

  14. Suttorp M, Claviez A, Bader P, et al. Allogeneic stem cell transplantation for treatment of chronic myeloid leukemia in pediatric and adolescent patients: results of the prospective trial CML-paed I. Klin Padiatr. 2009;221:351–7.

    Article  CAS  PubMed  Google Scholar 

  15. Hijiya N, Millot F, Suttorp M. Chronic myeloid leukemia in children: clinical findings, management, and unanswered questions. Pediatr Clin North Am. 2015;62:107–19.

    Article  PubMed  Google Scholar 

  16. Suttorp M, Millot F. Treatment of pediatric chronic myeloid leukemia in the year 2010: use of tyrosine kinase inhibitors and stem-cell transplantation. Hematology Am Soc Hematol Educ Program. 2010;2010:368–76.

    PubMed  Google Scholar 

  17. Pfeiffer M, Stanojevic S, Feuchtinger T, Greil J, Handgretinger R, Barbin K, Jung G, Martin D, Niethammer D, Lang P. Rituximab mediates in vitro antileukemic activity in pediatric patients after allogeneic transplantation. Bone Marrow Transplant. 2005;36:91–7.

    Article  CAS  PubMed  Google Scholar 

  18. Levine JE, Harris RE, Loberiza Jr FR, Armitage JO, Vose JM, Van Besien K, et al. A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood. 2003;101:2476–82.

    Article  CAS  PubMed  Google Scholar 

  19. Claviez A, Sureda A, Schmitz N. Haematopoietic SCT for children and adolescents with relapsed and refractory Hodgkin’s lymphoma. Bone Marrow Transplant. 2008;42 Suppl 2:S16–24.

    Article  PubMed  Google Scholar 

  20. Yalçin B, Kremer LC, Caron HN, van Dalen EC. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma. Cochrane Database Syst Rev. 2013;8:CD006301.

    Google Scholar 

  21. Peinemann F, van Dalen EC, Tushabe DA, Berthold F. Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation. Cochrane Database Syst Rev. 2015;1:CD010685.

    PubMed  Google Scholar 

  22. Navid F, Armstrong M, Barfield RC. Immune therapies for neuroblastoma. Cancer Biol Ther. 2009;8:874–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Krishnadas DK, Shapiro T, Lucas K. Complete remission following decitabine/dendritic cell vaccine for relapsed neuroblastoma. Pediatrics. 2013;131:e336–41.

    Article  PubMed  Google Scholar 

  24. Gennery AR, Slatter MA, Grandin L, Taupin P, Cant AJ, Veys P, et al. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol. 2010;126:602–10.e1–11.

    Article  PubMed  Google Scholar 

  25. Wahlstrom JT, Dvorak CC, Cowan MJ. Hematopoietic stem cell transplantation for severe combined immunodeficiency. Curr Pediatr Rep. 2015;3:1–10.

    Article  PubMed  PubMed Central  Google Scholar 

  26. http://www.ebmt.org/5WorkingParties/IEWP/wparties-ie5.html

  27. Veys P, Gaspar HB. HSCT for children and adolescents, primary immunodeficiency diseases. In: Apperley J, editor. EBMT handbook. 6th ed. Paris: ESH; 2012. p. 543–55.

    Google Scholar 

  28. Touzot F, Moshous D, Creidy R, Neven B, Frange P, Cros G, Caccavelli L, Blondeau J, Magnani A, Luby JM, Ternaux B, Picard C, Blanche S, Fischer A, Hacein-Bey-Abina S, Cavazzana M. Faster T-cell development following gene therapy compared to haplo-identical hematopoietic stem cell transplantation in the treatment of SCID-X1. Blood. 2015;125(3):3563–9. pii: blood-2014-12-616003.

    Article  CAS  PubMed  Google Scholar 

  29. Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Hanson IC, Filipovich AH, Jyonouchi S, Sullivan KE, Small TN, Burroughs L, Skoda-Smith S, Haight AE, Grizzle A, Pulsipher MA, Chan KW, Fuleihan RL, Haddad E, Loechelt B, Aquino VM, Gillio A, Davis J, Knutsen A, Smith AR, Moore TB, Schroeder ML, Goldman FD, Connelly JA, Porteus MH, Xiang Q, Shearer WT, Fleisher TA, Kohn DB, Puck JM, Notarangelo LD, Cowan MJ, O’Reilly RJ. Transplantation outcomes for severe combined immunodeficiency, 2000–2009. N Engl J Med. 2014;371:434–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Moratto D, Giliani S, Bonfim C, Mazzolari E, Fischer A, Ochs HD, et al. Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980–2009: an international collaborative study. Blood. 2011;118:1675–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Faitelson Y, Grunebaum E. Hemophagocytic lymphohistiocytosis and primary immune deficiency disorders. Clin Immunol. 2014;155:118–25.

    Article  CAS  PubMed  Google Scholar 

  32. Prasad VK, Mendizabal A, Parikh SH, Szabolcs P, Driscoll TA, Page K, Lakshminarayanan S, Allison J, Wood S, Semmel D, Escolar ML, Martin PL, Carter S, Kurtzberg J. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood. 2008;112:2979–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Orchard PJ, Tolar J. Transplant outcomes in leukodystrophies. Semin Hematol. 2010;47:70–8.

    Article  CAS  PubMed  Google Scholar 

  34. Noh H, Lee JI. Current and potential therapeutic strategies for mucopolysaccharidoses. J Clin Pharm Ther. 2014;39:215–24.

    Article  CAS  PubMed  Google Scholar 

  35. Boelens JJ, Aldenhoven M, Purtill D, Ruggeri A, Defor T, Wynn R, Wraith E, Cavazzana-Calvo M, Rovelli A, Fischer A, Tolar J, Prasad VK, Escolar M, Gluckman E, O’Meara A, Orchard PJ, Veys P, Eapen M, Kurtzberg J, Rocha V, Eurocord, Inborn Errors Working Party of European Blood and Marrow Transplant group, Duke University Blood and Marrow Transplantation Program, Centre for International Blood and Marrow Research. Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. Blood. 2013;121:3981–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Boelens JJ. HSCT in inborn errors of metabolism and osteopetrosis. In: Apperley J, editor. EBMT handbook. 6th ed. Paris: ESH; 2012. p. 559–69.

    Google Scholar 

  37. McKinney AM, Nascene D, Miller WP, Eisengart J, Loes D, Benson M, Tolar J, Orchard PJ, Ziegler RS, Zhang L, Provenzale J. Childhood cerebral X-linked adrenoleukodystrophy: diffusion tensor imaging measurements for prediction of clinical outcome after hematopoietic stem cell transplantation. AJNR Am J Neuroradiol. 2013;34:641–9.

    Article  CAS  PubMed  Google Scholar 

  38. Mazzolari E, Forino C, Razza A, Porta F, Villa A, Notarangelo LD. A single-center experience in 20 patients with infantile malignant osteopetrosis. Am J Hematol. 2009;84:473–9.

    Article  CAS  PubMed  Google Scholar 

  39. Nour M, Ward LM. Infantile malignant osteopetrosis. J Pediatr. 2013;163:1230.

    Article  PubMed  Google Scholar 

  40. Corbacioglu S, Hönig M, Lahr G, Stöhr S, Berry G, Friedrich W, Schulz AS. Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide. Bone Marrow Transplant. 2006;38:547–53.

    Article  CAS  PubMed  Google Scholar 

  41. Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, Pagliuca A, Veys P, Potter MN, Haemato-oncology Task Force of British Committee for Standards in Haematology, British Society for Blood and Marrow Transplantation. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol. 2013;163:444–57.

    Article  CAS  PubMed  Google Scholar 

  42. Steward CG, Pellier I, Mahajan A, Ashworth MT, Stuart AG, Fasth A, Lang D, Fischer A, Friedrich W, Schulz AS, Working Party on Inborn Errors of the European Blood and Marrow Transplantation Group. Severe pulmonary hypertension: a frequent complication of stem cell transplantation for malignant infantile osteopetrosis. Br J Haematol. 2004;124:63–71.

    Article  CAS  PubMed  Google Scholar 

  43. Shroff R, Beringer O, Rao K, Hofbauer LC, Schulz A. Denosumab for post-transplantation hypercalcemia in osteopetrosis. N Engl J Med. 2012;367:1766–7.

    Article  CAS  PubMed  Google Scholar 

  44. Bagby GC, Alter BP. Fanconi anemia. Semin Hematol. 2006;43:147–56.

    Article  CAS  PubMed  Google Scholar 

  45. Socié G, Devergie A, Girinski T, Piel G, Ribaud P, Esperou H, et al. Transplantation for Fanconi’s anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol. 1998;103:249–55.

    Article  PubMed  Google Scholar 

  46. Pasquini R, Carreras J, Pasquini MC, Camitta BM, Fasth AL, Hale GA, et al. HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. Biol Blood Marrow Transplant. 2008;14:1141–7.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Peffault de Latour R, Porcher R, Dalle JH, Aljurf M, Korthof ET, Svahn J, Willemze R, Barrenetxea C, Mialou V, Soulier J, Ayas M, Oneto R, Bacigalupo A, Marsh JC, Peters C, Socie G, Dufour C, FA Committee of the Severe Aplastic Anemia Working Party, Pediatric Working Party of the European Group for Blood and Marrow Transplantation. Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. Blood. 2013;122:4279–86.

    Article  CAS  PubMed  Google Scholar 

  48. Mitchell R, Wagner JE, Hirsch B, DeFor TE, Zierhut H, MacMillan ML. Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in Fanconi anaemia. Br J Haematol. 2014;164:384–95.

    Article  CAS  PubMed  Google Scholar 

  49. Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M, Bodhi P, Davis J, Davies SM, Deconinck E, Deeg HJ, Duerst RE, Fasth A, Ghavamzadeh A, Giri N, Goldman FD, Kolb EA, Krance R, Kurtzberg J, Leung WH, Srivastava A, Or R, Richman CM, Rosenberg PS, Toledo Codina JS, Shenoy S, Socié G, Tolar J, Williams KM, Eapen M, Savage SA. Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant. 2013;19:1238–43.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Vlachos A, Ball S, Dahl N, Alter BP, Sheth S, Ramenghi U, Meerpohl J, Karlsson S, Liu JM, Leblanc T, Paley C, Kang EM, Leder EJ, Atsidaftos E, Shimamura A, Bessler M, Glader B, Lipton JM, Participants of Sixth Annual Daniella Maria Arturi International Consensus Conference. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol. 2008;142:859–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Fagioli F, Quarello P, Zecca M, Lanino E, Corti P, Favre C, Ripaldi M, Ramenghi U, Locatelli F, Prete A. Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry. Br J Haematol. 2014;165:673–81.

    Article  PubMed  Google Scholar 

  52. Mugishima H, Ohga S, Ohara A, Kojima S, Fujisawa K, Tsukimoto I, Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology. Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology. Pediatr Transplant. 2007;11:601–7.

    Article  CAS  PubMed  Google Scholar 

  53. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C, Politi P, Durazzi SM, Muretto P, Albertini F. Bone marrow transplantation in patients with thalassemia. N Engl J Med. 1990;322:417–21.

    Article  CAS  PubMed  Google Scholar 

  54. Angelucci E. Hematopoietic stem cell transplantation in thalassemia. Hematology Am Soc Hematol Educ Program. 2010;2010:456–62.

    PubMed  Google Scholar 

  55. Sodani P, Gaziev D, Polchi P, Erer B, Giardini C, Angelucci E, et al. New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. Blood. 2004;104:1201–3.

    Article  CAS  PubMed  Google Scholar 

  56. Bernardo ME, Piras E, Vacca A, Giorgiani G, Zecca M, Bertaina A, Pagliara D, Contoli B, Pinto RM, Caocci G, Mastronuzzi A, La Nasa G, Locatelli F. Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan. Blood. 2012;120:473–6.

    Article  CAS  PubMed  Google Scholar 

  57. Unal S, Kuskonmaz B, Hazirolan T, Eldem G, Aytac S, Cetin M, et al. Deferasirox use after hematopoietic stem cell transplantation in pediatric patients with beta-thalassemia major: preliminary results. Pediatr Hematol Oncol. 2010;27:482–9.

    Article  PubMed  Google Scholar 

  58. Gluckman E. Allogeneic transplantation strategies including haploidentical transplantation in sickle cell disease. Hematology Am Soc Hematol Educ Program. 2013;2013:370–6.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Hematology, Hacettepe University, Ankara, Turkey

    Sule Unal M.D.

  2. Division of Pediatric Hematology/BMT Unit, Hacettepe University, Ankara, Turkey

    Duygu Uckan-Cetınkaya M.D.

  3. Faculty of Medicine, Hematology Division, Department of Pediatrics, Hacettepe University, Sihhiye, Ankara, 06100, Turkey

    Duygu Uckan-Cetınkaya M.D.

Authors
  1. Sule Unal M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Duygu Uckan-Cetınkaya M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Duygu Uckan-Cetınkaya M.D. .

Editor information

Editors and Affiliations

  1. Center of Excellence for Stem Cells and Regenerative Medicine, Zewail City of Science and Technology, Zayed City, Egypt

    Nagwa El-Badri

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Unal, S., Uckan-Cetınkaya, D. (2017). Hematopoietic Stem Cell Transplantation in Pediatric Diseases. In: El-Badri, N. (eds) Advances in Stem Cell Therapy. Stem Cell Biology and Regenerative Medicine. Humana Press, Cham. https://doi.org/10.1007/978-3-319-29149-9_1

Download citation

Publish with us

Policies and ethics

Search

Navigation